Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
72.66
Aug 07 • 3:59 PM ET Dollar change-4.61 Percentage change(-5.97%)
Aftermarket Close
73.14
Aftermarket • 7:59 PM ET Dollar change+0.48 Percentage change(0.66%)
Aug 06, 10:23 PMZoetis cuts 2026 guidance to revenue $9.12–$9.32B, EPS $6.15–$6.25 amid intensifying U.S. Companion Animal, pricing pressures
Index
S&P 500
Market Cap
30.46B
Enterprise Value
38.02B
Income
2.62B
Sales
9.52B
Book/sh
7.60
Cash/sh
4.00
Employees
14500
IPO
Feb 01, 2013
P/E
11.95
Forward P/E
10.76
PEG
2.50
P/S
3.20
P/B
9.56
P/C
18.17
P/FCF
12.87
EV/EBITDA
9.35
EV/Sales
4.00
Quick Ratio
1.84
Current Ratio
3.08
Debt/Eq
2.93
LT Debt/Eq
2.93
Option/Short
Yes / Yes
EPS (ttm)
6.08
EPS next Y
6.75
EPS next Q
1.60
EPS this Y
0.75%
EPS next Y
4.55%
EPS next 5Y
4.30%
EPS past 3/5Y
10.25% 11.96%
Sales past 3/5Y
5.42% 7.24%
EPS Y/Y TTM
4.54%
Sales Y/Y TTM
1.41%
EPS Q/Q
2.64%
Sales Q/Q
0.33%
Insider Own
0.56%
Insider Trans
-0.35%
Inst Own
97.75%
Inst Trans
-1.65%
ROA
17.70%
ROE
64.39%
ROIC
21.12%
Gross Margin
70.22%
Oper. Margin
37.65%
Profit Margin
27.49%
SMA20
-4.16%
SMA50
-5.29%
SMA200
-33.19%
Trades
Shs Outstand
419.23M
Shs Float
416.86M
52W High
160.48 -54.72%
52W Low
71.47 1.67%
Volatility
5.81% 3.42%
ATR (14)
3.04
RSI (14)
40.08
Beta
0.73
Rel Volume
1.62
Avg Volume
7.91M
Volume
12,784,555
Perf Week
-5.99%
Perf Month
-3.22%
Perf Quarter
-16.78%
Perf Half Y
-42.67%
Perf YTD
-42.25%
Perf Year
-50.98%
Perf 3Y
-59.79%
Perf 5Y
-64.01%
Perf 10Y
42.22%
Prev Close
77.27
Price
72.66
Change %
-5.97%
Date Action Analyst Rating Change Price Target Change
Aug-06-26Downgrade William Blair Outperform → Mkt Perform
May-27-26Downgrade Argus Buy → Hold
Apr-15-26Initiated Citigroup Buy $145
Jan-22-26Downgrade Piper Sandler Overweight → Neutral $135
Dec-15-25Downgrade BofA Securities Buy → Neutral $135
Dec-09-25Initiated Barclays Equal Weight $136
Nov-21-25Initiated KeyBanc Capital Markets Sector Weight
Jul-17-25Downgrade Leerink Partners Outperform → Market Perform $155
Jun-18-25Downgrade Stifel Buy → Hold $160
Dec-02-24Initiated Leerink Partners Outperform $215
Today 07:58PM
04:30PM
10:31AM
Aug-06-26 07:16PM
05:52PM
05:51PM Loading…
05:51PM
07:18AM
07:00AM
07:00AM
Jul-31-26 12:52PM
12:21PM
Jul-30-26 05:38PM
Jul-27-26 02:01PM
Jul-22-26 07:30AM
Jul-20-26 03:46AM
08:30AM Loading…
Jul-15-26 08:30AM
Jul-07-26 07:00AM
Jul-06-26 07:00AM
Jul-02-26 08:48PM
Jul-01-26 06:59AM
Jun-27-26 08:55PM
Jun-25-26 08:30AM
04:59AM
Jun-15-26 02:36AM
Jun-11-26 03:27AM
Jun-04-26 10:23AM
Jun-03-26 02:57AM
May-27-26 09:35AM
May-21-26 08:30AM
May-20-26 04:15PM
04:30PM Loading…
May-11-26 04:30PM
May-07-26 08:45PM
04:30PM
12:09PM
11:47AM
07:59AM
07:59AM
07:08AM
07:00AM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-02-26 08:30AM
Mar-23-26 01:38PM
Mar-16-26 04:19AM
Mar-14-26 02:49PM
Mar-12-26 08:30AM
Mar-06-26 09:40AM
09:30AM
07:54AM
Mar-05-26 08:30AM
Mar-02-26 07:00AM
04:07AM
Mar-01-26 05:06AM
Feb-27-26 04:51PM
11:00AM
05:29AM
Feb-26-26 11:03PM
Feb-24-26 04:22PM
09:50AM
08:30AM
Feb-23-26 10:57AM
Feb-19-26 12:38AM
Feb-18-26 10:05AM
09:40AM
04:01AM
Feb-13-26 04:57PM
07:13AM
12:35AM
Feb-12-26 04:15PM
04:05PM
01:24PM
12:32PM
10:30AM
09:30AM
08:45AM
08:10AM
07:46AM
07:38AM
07:05AM
07:00AM
05:36AM
04:50AM
Feb-10-26 10:09PM
10:00AM
Feb-09-26 11:30AM
10:22AM
09:15AM
08:55AM
Feb-06-26 08:57AM
Feb-05-26 04:15PM
12:22PM
10:00AM
09:50AM
Feb-04-26 02:18PM
Feb-03-26 06:15PM
11:40AM
10:00AM
09:45AM
08:14AM
Jan-31-26 12:35PM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
CEO & DirectorMs. Kristin C. Peck
Executive VP & CFOMr. Wetteny N. Joseph CPA
Executive VPMs. Roxanne Lagano
Scientific AdvisorDr. Robert J. Polzer Ph.D.
Executive VP & Chief Commercial OfficerMr. Jamie Brannan
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK ADirectorMay 13 '26Buy75.396,650501,34421,458May 13 04:35 PM
Bisaro PaulDirectorMay 13 '26Buy75.882,000151,75027,862May 13 04:35 PM
MCCALLISTER MICHAEL BDirectorMay 11 '26Buy77.763,000233,27324,524May 12 07:26 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Option Exercise41.8320,000836,600121,337Feb 17 04:22 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Sale127.0520,0002,540,964101,337Feb 17 04:22 PM
Polzer Robert JOfficerFeb 17 '26Proposed Sale127.342,346298,742Feb 17 04:14 PM
PECK KRISTIN COfficerFeb 17 '26Proposed Sale127.0520,0002,540,964Feb 17 04:13 PM
Polzer Robert JOfficerFeb 13 '26Proposed Sale129.093,662472,728Feb 13 04:26 PM